APA (7th ed.) Citation

Spring, L. (2018). Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer. The American Association for Cancer Research (AACR).

Chicago Style (17th ed.) Citation

Spring, L. Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer. The American Association for Cancer Research (AACR), 2018.

MLA (9th ed.) Citation

Spring, L. Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer. The American Association for Cancer Research (AACR), 2018.